Prosecution Insights
Last updated: October 25, 2026

Institute of Materia Medica, Chinese Academy of Medical Sciences

Technology area: Biotechnology & Pharmaceuticals

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days

Analysis

Institute of Materia Medica, Chinese Academy of Medical Sciences has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This single action is assigned to 1 distinct examiner and 1 distinct art unit. The examiner responsible for this case is WHITE, DAWANNA SHAR-DAY, who is also listed as the busiest examiner with 1 pending office action.

Because there is only 1 pending office action, the entire prosecution profile for the company at this moment rests with WHITE, DAWANNA SHAR-DAY. This concentration means that the outcome of the company's current patenting activity is entirely dependent on the interaction with this 1 distinct examiner. Practitioners should focus on the specific examination history of WHITE, DAWANNA SHAR-DAY within the 1 distinct art unit to anticipate potential hurdles for this single pending action.

The presence of 1 distinct art unit within the Biotechnology & Pharmaceuticals sector suggests a focused technical review for the pending matter. With 1 pending office action, the company can dedicate its resources to addressing the specific concerns of the assigned examiner. WHITE, DAWANNA SHAR-DAY, as the busiest examiner with 1 pending action, represents the sole point of contact for the company's active prosecution. This structure allows for a direct and focused interaction between the practitioner and the examiner to resolve the 1 pending office action.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
1
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (100%)
0
Medium (0%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
Multi-statute (no §101)1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
WHITE, DAWANNA SHAR-DAY 1 62.4% +24.3%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18860199 DRUG SUSTAINED-RELEASE TABLET FOR TREATING LIVER DISEASE, PREPARATION METHOD THEREFOR AND USE THEREOF WHITE, DAWANNA SHAR-DAY —

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18860199 DRUG SUSTAINED-RELEASE TABLET FOR TREATING LIVER DISEASE, PREPARATION METHOD THEREFOR AND USE THEREOF WHITE, DAWANNA SHAR-DAY —

Top Art Units

Art UnitApps
1629 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18860199 DRUG SUSTAINED-RELEASE TABLET FOR TREATING LIVER DISEASE, PREPARATION METHOD THEREFOR AND USE THEREOF WHITE, DAWANNA SHAR-DAY 1629 §103§112Other Non-Final OA — Pending Oct 25, 2024

Managing Institute of Materia Medica, Chinese Academy of Medical Sciences's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Institute of Materia Medica, Chinese Academy of Medical Sciences have?

Institute of Materia Medica, Chinese Academy of Medical Sciences has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.

Which USPTO examiner handles the most Institute of Materia Medica, Chinese Academy of Medical Sciences applications?

Dawanna Shar-Day White has the most, with 1 of Institute of Materia Medica, Chinese Academy of Medical Sciences's pending office actions.

What technology area are Institute of Materia Medica, Chinese Academy of Medical Sciences's patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month